 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Apellis Pharmaceuticals Inc. (APLS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-15 Sale | 2021-01-19 4:05 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $53.15 | $132,875 | 669,544 (Indirect Direct) | View |
| 2021-02-01 Sale | 2021-02-02 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 600 | $44 | $26,400 | 59,602 (Direct) | View |
| 2021-02-09 Sale | 2021-02-10 4:37 pm | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,000 | $50 | $100,000 | 2,500 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $46 | $115,000 | 669,544 (Indirect Direct) | View |
| 2021-02-16 Sale | 2021-02-17 4:12 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 500 | $46 | $23,000 | 58,414 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:03 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 600 | $48.58 | $29,148 | 57,814 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:05 pm | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,000 | $50 | $100,000 | 2,347 (Direct) | View |
| 2021-03-05 Sale | 2021-03-08 4:32 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 5,000 | $48.62 | $243,075 | 57,814 (Direct) | View |
| 2021-03-10 Sale | 2021-03-11 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 6,250 | $50.74 | $317,125 | 865,087 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 4:14 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 500 | $46.77 | $23,385 | 57,314 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 4:16 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $46.77 | $116,925 | 669,544 (Indirect Direct) | View |
| 2021-04-01 Sale | 2021-04-05 5:11 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 600 | $43.41 | $26,046 | 56,714 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-15 Exercise | 2021-01-19 4:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 672,044 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 4:05 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $0 | 155,029 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-26 4:25 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 3,500 | $3.2 | 39,327 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-26 4:25 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 11,500 | $3.76 | 50,827 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-26 4:25 pm | N/A 2024-12-12 | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 3,500 | $0 | 39,073 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-26 4:25 pm | N/A 2026-02-06 | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 11,500 | $0 | 23,661 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 23,441 | $3.76 | 66,845 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 20,042 | $4.31 | 86,887 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A 2026-02-06 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 23,441 | $0 | 0 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:18 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 20,042 | $0 | 3,399 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 39,785 | $3.76 | 1,152,864 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 31,992 | $4.31 | 1,184,856 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:19 pm | N/A 2026-02-06 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 39,785 | $0 | 273,840 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-29 4:19 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 31,992 | $0 | 389,948 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 7,500 | $0 | 863,900 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 1,875 | $0 | 865,775 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:34 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:34 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:35 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,500 | $0 | 2,500 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:35 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:35 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 5,000 | $0 | 8,928 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:35 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:36 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey VP | 5,000 | $0 | 6,211 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:36 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey VP | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $0 | 5,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,250 | $0 | 6,250 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:37 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:37 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:38 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur CTO | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:38 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur CTO | 1,875 | $0 | 9,375 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:38 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur CTO | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:38 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur CTO | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:39 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CIO | 7,500 | $0 | 28,095 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:39 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CIO | 1,875 | $0 | 29,970 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:39 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CIO | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:39 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CIO | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,500 | $0 | 94,387 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 1,875 | $0 | 96,262 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:40 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:40 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 7,500 | $0 | 31,369 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 3,750 | $0 | 35,119 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 25,000 | $0 | 1,209,856 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 12,500 | $0 | 1,222,356 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:43 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 7,500 | $0 | 58,327 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:43 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 1,875 | $0 | 60,202 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:43 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:43 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:44 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 7,500 | $0 | 17,678 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:44 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 1,875 | $0 | 19,553 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:44 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:44 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 11,250 | $0 | 11,250 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-10 4:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,000 | $3.76 | 4,500 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-10 4:37 pm | N/A 2025-07-31 | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,000 | $0 | 13,161 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 468 | $47.72 | 95,794 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 2,523 | $47.72 | 1,219,833 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 688 | $47.72 | 58,914 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 144 | $47.72 | 8,784 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 688 | $47.72 | 18,865 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 688 | $47.72 | 865,087 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:14 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 153 | $47.72 | 2,347 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 858 | $47.72 | 34,261 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CIO | 680 | $47.72 | 29,290 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-17 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 672,044 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-17 4:11 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $0 | 152,529 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 4:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,000 | $3.76 | 4,347 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 4:05 pm | N/A 2025-07-31 | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,000 | $0 | 11,161 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey VP | 1,250 | $0 | 7,461 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:07 pm | N/A 2031-02-28 | Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey VP | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-08 4:32 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 5,000 | $3.2 | 62,814 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-08 4:32 pm | N/A 2024-12-12 | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 5,000 | $0 | 34,073 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-11 4:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 6,250 | $2.67 | 871,337 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-11 4:08 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 6,250 | $0 | 392,249 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 4:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 672,044 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 4:16 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $0 | 150,029 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-19 5:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 1,250 | $0 | 10,034 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-19 5:58 pm | N/A 2031-02-28 | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-23 4:14 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 978 | $4.31 | 96,772 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-23 4:14 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 978 | $0 | 2,421 (Direct) | View |
| 2021-03-25 Tax Withholding | 2021-03-29 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 82 | $41.16 | 9,952 (Direct) | View |